SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (5193)4/7/2020 6:12:33 PM
From: Elroy Jetson  Read Replies (1) of 13800
 
Men between the ages of 40 and 64 are most heavily affected by SARS-CoV-2.

SARS-CoV-2 coexists with the elderly quite well, so long as they're not taking ACE inhibitor blood pressure medication or a glitazone for diabetes. Both medications greatly increase the number of Angiotensin-II receptors on cells which act as the cell entry for the virus.

There's a nursing home a mile from here where two men, one 86 and the other 94, who became the first people infected with the CoV-2 virus in my city council district. Both are doing perfectly fine without requiring hospitalization or oxygen, as is the 34 year old woman carer now at home who also became infected looking after them both.

The idea that the SARS-CoV-2 virus primarily kills the elderly and those with suppressed immune systems is nothing more than an often repeated conspiracy theory popular with Trump goons.

Men between 40 and 64 make up the majority of those on respirators in California, South Korea, Taiwan, Germany and most places other Italy. If you're 65 or older you're relatively low-risk like those under the age of 40. Those under the age of 17 are the lowest risk.

The 58 year old director of the City-funded non-profit which partly funds our ceramic studio died after 8 days on a respirator. Like Boris Johnson he was a windbag, hugely impressed with himself, but otherwise in good health.

What's with Italy? The Italian health service still prescribes glitazones rather than gliptins and hasn't replaced ACE inhibitors with 'newer' ARB meds. The 'newer' drugs are already off patent and Italy doesn't even enforce drug patents. So Italy was an anomaly.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext